Cronos Group (CRON) Competitors C$3.78 +0.04 (+1.07%) As of 11:04 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock CRON vs. APHA, PBH, BHC, TLRY, AUP, CARA, SLS, TEV, ABT, and NOTShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aphria (APHA), Premium Brands (PBH), Bausch Health Companies (BHC), Tilray Brands (TLRY), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Solaris Resources (SLS), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), and Noront Resources (NOT). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Its Competitors Aphria Premium Brands Bausch Health Companies Tilray Brands Aurinia Pharmaceuticals Cara Operations Solaris Resources Tervita Absolute Software Co. (ABT.TO) Noront Resources Aphria (TSE:APHA) and Cronos Group (TSE:CRON) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Is APHA or CRON more profitable? Aphria has a net margin of 0.00% compared to Cronos Group's net margin of -42.65%. Aphria's return on equity of 0.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets AphriaN/A N/A N/A Cronos Group -42.65%-4.40%-3.73% Which has higher valuation & earnings, APHA or CRON? Cronos Group has lower revenue, but higher earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAphriaC$611.06M0.00-C$637.39M-C$2.01N/ACronos GroupC$130.28M11.11-C$32.78MC$0.0575.60 Does the media refer more to APHA or CRON? In the previous week, Cronos Group's average media sentiment score of 0.67 beat Aphria's score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media. Company Overall Sentiment Aphria Neutral Cronos Group Positive Do institutionals & insiders hold more shares of APHA or CRON? 4.6% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryCronos Group beats Aphria on 6 of the 10 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$1.45BC$1.73BC$9.08BC$9.69BDividend YieldN/A2.95%5.69%6.48%P/E Ratio75.60113.8086.1626.90Price / Sales11.111,565.20539.9211.40Price / Cash1.6710.3737.9283.29Price / Book1.2811.5513.055.80Net Income-C$32.78MC$20.70BC$3.30BC$301.20M7 Day Performance4.42%1.21%4.55%2.26%1 Month Performance6.48%4.10%9.73%7.96%1 Year Performance31.25%10.33%85.10%43.84% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos GroupN/AC$3.78+1.1%N/A+26.8%C$1.45BC$130.28M75.60450APHAAphriaN/AN/AN/AN/AC$5.24BC$611.06M-8.231,200PBHPremium Brands3.01 of 5 starsC$93.50+0.1%C$111.18+18.9%+1.5%C$4.18BC$6.90B44.95540News CoverageAnalyst ForecastBHCBausch Health CompaniesN/AC$9.26+3.3%N/A-19.5%C$3.42BC$9.86B35.6219,900TLRYTilray BrandsN/AC$2.33-2.9%N/A+6.6%C$2.61BC$821.31M-0.952,650News CoverageGap UpAUPAurinia PharmaceuticalsN/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading VolumeCARACara OperationsN/AN/AN/AN/AC$1.62BN/A0.0080SLSSolaris Resources1.6558 of 5 starsC$9.13+2.8%C$13.50+47.9%+185.7%C$1.51BN/A-22.2710TEVTervitaN/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap UpABTAbsolute Software Co. (ABT.TO)N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading VolumeNOTNoront ResourcesN/AC$1.10-0.5%N/A+0.0%C$612.18MN/A-7.20101,700 Related Companies and Tools Related Companies Aphria Alternatives Premium Brands Alternatives Bausch Health Companies Alternatives Tilray Brands Alternatives Aurinia Pharmaceuticals Alternatives Cara Operations Alternatives Solaris Resources Alternatives Tervita Alternatives Absolute Software Co. (ABT.TO) Alternatives Noront Resources Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRON) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
